Anxiety Disorder, Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Depression, Psychosocial Effects of Cancer and Its Treatment
Conditions
Keywords
anxiety disorder, depression, cognitive/functional effects, psychosocial effects of cancer and its treatment, cancer survivor, breast cancer
Brief summary
RATIONALE: Mindful movement is a self-directed activity of mindfulness (intention, attention, and attitude) and physical movement. A mindful movement program may be effective in improving well-being in older women who are breast cancer survivors. PURPOSE: This randomized clinical trial is studying how well a mindful movement program works in improving quality of life in older female breast cancer survivors.
Detailed description
OBJECTIVES: * To test the effects of the 12-week Mindful Movement Program on quality of life in older female breast cancer survivors. * To test the effects of this program on mindfulness outcomes in these participants. * To compare mindfulness qualities in the experimental group with the control group. * To determine the qualitative benefits of this program as described by these participants. OUTLINE: Participants are randomized to 1 of 2 intervention arms. * Arm I (Mindful Movement Program \[MMP\]): Participants undergo a 2-hour MMP session once weekly for 12 weeks. Participants are encouraged to practice intentional-mindful movement at home 5 minutes daily during weeks 1-4, 10 minutes daily during weeks 5-8, and 15 minutes daily during weeks 9-12. Mindful movement is a self-directed activity incorporating mindfulness concepts and physical movement. Mindfulness consists of the three core elements: intention (reasons for participating in a mindfulness intervention), attention (observing experiences in the present moment), and attitude (nonjudgmental openness and acceptance of experiences). Each MMP session includes verbal sharing with a partner and the group and movement individually and with a partner, while focusing on the elements of mindfulness. Music is incorporated into some portion of each session. * Arm II (control): Participants undergo no intervention. All participants complete questionnaires for sociodemographic and individual characteristics, quality of life (including psychological, social, spiritual, and physical well-being, anxiety and depression, fear of recurrence, body image, and upper body symptoms), movement, and mindfulness (including attention, self-compassion, and intention) at baseline and weeks 12 and 18. PROJECTED ACCRUAL: A total of 75 participants (45 in the experimental group and 30 in the control group) will be accrued for this study.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
DISEASE CHARACTERISTICS: * Breast cancer survivor * At least 12 months since completion of treatment (chemotherapy, biotherapy \[e.g., trastuzumab\], or radiotherapy) * No evidence of metastatic disease PATIENT CHARACTERISTICS: * English speaking * Not under acute psychological distress * Not using an assistive device (cane, walker, or wheelchair) * Able to participate in the Mindful Movement Program by a medical release from the patient's physician * Pregnancy allowed PRIOR CONCURRENT THERAPY: * See Disease Characteristics * Concurrent selective estrogen-receptor modulator permitted * No other concurrent treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effects of the Mindful Movement Program on psychological well-being, distress, fear of recurrence, physical well-being, upper-body symptom bother, social well-being, body image, and spiritual well-being at baseline and weeks 12 and 18 | 6 months after study entry |
| Effects of this program on attention and attitude | 6 months after study entry |
| Differences of attention and attitude between the experimental group and the control group | 6 months after study entry |
| Perceptions of the program as described by the experimental group | 6 months after entry |
Countries
United States